ArticleSystematic reviews2025
Development of a PRISMA extension for systematic reviews of health economic evaluations (PRISMA-EconEval): a project protocol.
Article in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSystematic reviews of health economic evaluations are key for evidence-based decisions but lack standardised reporting. This project aims to develop a Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) extension for systematic reviews of health economic evaluations (PRISMA-EconEval).
methodsProject stages include the following: (1) scoping review, (2) Delphi surveys, (3) consensus meeting, (4) piloting, and (5) finalisation and dissemination. The project is overseen by the international multidisciplinary PRISMA-EconEval Management Group (PMG), Advisory Group, and Patient and Public Involvement Group. (1) The scoping review aims to identify candidate reporting items, with the protocol published elsewhere. The global applicability of these items to systematic reviews of health economic evaluations will be evaluated using sample papers from the scoping review, supplemented by nominations from the health economics community or other sources, where necessary. (2) A multi-round online Delphi survey will be conducted to achieve consensus on items for inclusion. A purposive sample of panellists (approximately 200) will be selected, ensuring representation of the following: health economists, systematic reviewers, information specialists, guideline developers, journal editors, healthcare decision-makers, research funders, and public representatives. Across two to three rounds, panellists will use a 1-9 scale to rate each candidate item's ability to represent the minimum required for reporting, be relevant to all systematic reviews of health economic evaluations, facilitate complete and transparent reporting, and support the quality assessment of both the review and included studies. (3) An online consensus meeting (approximately 30 participants) will refine the wording of items and resolve any disagreements by vote. (4) Health economists independent of the project will apply the draft guidelines to a sample of published studies and identify practical challenges. (5) The PMG will meet to finalise the wording and presentation of the reporting items, ensure consistency with PRISMA 2020, and produce an explanation and elaboration document. Dissemination channels will include peer-reviewed health economics journals, conferences, and the EQUATOR network. DISCUSSION: PRISMA-EconEval aims to improve clarity, consistency, transparency, quality, and overall value of systematic reviews of health economic evaluations. This will benefit researchers, peer reviewers, editors, decision-makers, and ultimately patients and the public through supporting decisions on healthcare resource allocation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.